BioBunBan's strategy encompasses the development of products aligned with global market demands and the expansion of distribution channels. Additionally, the company has entered into a memorandum of understanding with Gentech International Health Integration, aiming to expedite the scale-up and international market entry process.
The 紳太International Health Integrator offers a distinctive approach to business incubation and acceleration. Unlike traditional incubators and accelerators, it focuses on a select group of 1-100 start-ups, providing tailored coaching to support their growth and expansion into international markets. The Integrator is staffed by a group of experienced professionals from various industries who provide market-valuable, specialised, and precise coaching with the expectation of scaling up the team to achieve maximum potential. The fusion of international market trends, market demand-driven strategies, branding channels, revenue and cost integration, and cross-disciplinary integration of start-ups into the greatest cohesion helps start-ups expand profits as soon as possible, creating a win-win situation for both founders and investors. Providing comprehensive support will assist Taiwanese AI and biomedical health start-ups in expanding their international market presence and navigating the challenges of the real market environment. This will enable them to establish an efficient, time-saving and mutually beneficial win-win industrial ecosystem.
Source:https://money.udn.com/money/story/11799/8053879